Sex differences in catheter ablation of atrial fibrillation: results from AXAFA-AFNET 5
Open Access
- 1 July 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 22 (7) , 1026-1035
Abstract
Study sex-differences in efficacy and safety of atrial fibrillation (AF) ablation. We assessed first AF ablation outcomes on continuous anticoagulation in 633 patients [209 (33%) women and 424 (67%) men] in a pre-specified subgroup analysis of the AXAFA-AFNET 5 trial. We compared the primary outcome (death, stroke or transient ischaemic attack, or major bleeding) and secondary outcomes [change in quality of life (QoL) and cognitive function] 3 months after ablation. Women were older (66 vs. 63 years, P < 0.001), more often symptomatic, had lower QoL and a longer history of AF. No sex differences in ablation procedure were found. Women stayed in hospital longer than men (2.1 ± 2.3 vs. 1.6 ± 1.3 days, P = 0.004). The primary outcome occurred in 19 (9.1%) women and 26 (6.1%) men, P = 0.19. Women experienced more bleeding events requiring medical attention (5.7% vs. 2.1%, P = 0.03), while rates of tamponade (1.0% vs. 1.2%) or intracranial haemorrhage (0.5% vs. 0%) did not differ. Improvement in QoL after ablation was similar between the sexes [12-item Short Form Health Survey (SF-12) physical 5.1% and 5.9%, P = 0.26; and SF-12 mental 3.7% and 1.6%, P = 0.17]. At baseline, mild cognitive impairment according to the Montreal Cognitive Assessment (MoCA) was present in 65 (32%) women and 123 (30%) men and declined to 23% for both sexes at end of follow-up. Women and men experience similar improvement in QoL and MoCA score after AF ablation on continuous anticoagulation. Longer hospital stay, a trend towards more nuisance bleeds, and a lower overall QoL in women were the main differences observed.Keywords
Funding Information
- Pfizer
- BMS
- German Centre for Cardiovascular Research
- German Ministry of Education and Research
- European Union (633196)
- European Union BigData@Heart (EU IMI 116074)
- British Heart Foundation (FS/13/43/30324, PG/17/30/32961, AA/18/2/34218)
- Leducq Foundation
This publication has 20 references indexed in Scilit:
- Sex-related outcome of atrial fibrillation ablation: Insights from the German Ablation RegistryHeart Rhythm, 2016
- Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and MenJAMA Cardiology, 2016
- Five-year efficacy of pulmonary vein antrum isolation as a primary ablation strategy for atrial fibrillation: a single-centre cohort studyEP Europace, 2016
- Temporal trends and sex differences in pulmonary vein isolation for patients with atrial fibrillationHeart Rhythm, 2015
- Effects of Sex on the Incidence of Cardiac Tamponade After Catheter Ablation of Atrial FibrillationCirculation: Arrhythmia and Electrophysiology, 2014
- Long‐term Outcomes of Catheter Ablation of Atrial Fibrillation: A Systematic Review and Meta‐analysisJournal of the American Heart Association, 2013
- 3 Tesla MRI‐Detected Brain Lesions after Pulmonary Vein Isolation for Atrial Fibrillation: Results of the MACPAF StudyJournal of Cardiovascular Electrophysiology, 2012
- Standardized Bleeding Definitions for Cardiovascular Clinical TrialsCirculation, 2011
- Predictors of Atrial Fibrillation Recurrence After Radiofrequency Catheter Ablation: A Systematic ReviewJournal of Cardiovascular Electrophysiology, 2010
- Outcomes and complications of catheter ablation for atrial fibrillation in femalesHeart Rhythm, 2010